Reid Hoffman stepped down from Microsoft's board to focus on his AI drug discovery startup Manus. Hoffman joined the board after Microsoft bought LinkedIn for $26.2 billion in 2016. Manus raised over $50 million in seed rounds and is led by CEO Dr. Siddhartha Mukherjee. Hoffman cited a need to go "founder mode" as the startup works on AI to combat cancers.
Tap to vote and see what everyone thinks.
Anthropic Files for IPO, Raising Race with OpenAI and SpaceX
Summary by ByteBrief